MetaADEDB 2.0 @ LMMD
irsogladine
(ATCGGEJZONJOCL-UHFFFAOYSA-N)
Structure
SMILES
Clc1ccc(c(c1)c1nc(N)nc(n1)N)Cl
Type(s)
Investigational
Molecular Formula:
C9H7Cl2N5
Molecular Weight:
256.091
Log P:
3.1722
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
2
TPSA:
90.71
CAS Number(s):
57381-26-7
Synonym(s)
1.
irsogladine
2.
2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate
3.
6-(2,5-dichlorophenyl)-2,4-diamino-1,3,5-triazine
4.
DCPDAT
5.
MN 1695
6.
MN-1695
7.
irsogladine maleate
External Link(s)
MeSHC041836
PubChem Compound3752
BindingDB69900
ChEBI93307
CHEMBLCHEMBL136497
DrugBankDB13056
DrugCentral1484
KEGGdr:D08087
ZINC2645
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute bronchitisOFFSIDES
2Adverse eventOFFSIDES
3AgnosiaOFFSIDES
4AlopeciaOFFSIDES
5Altered state of consciousnessOFFSIDES
6AlveolitisOFFSIDES
7Ammonia increasedOFFSIDES
8Anti-insulin antibody decreasedOFFSIDES
9Anticholinergic SyndromeOFFSIDES
10ApathyOFFSIDES
11AscitesOFFSIDES
12Aspartate aminotransferase decreasedOFFSIDES
13Atlantoaxial instabilityOFFSIDES
14Autoimmune hepatitisOFFSIDES
15Bladder cancer recurrentOFFSIDES
16Bladder stenosisOFFSIDES
17Blood aldosterone increasedOFFSIDES
18Blood chloride decreasedOFFSIDES
19Blood creatine phosphokinase increasedOFFSIDES
20Blood creatinine decreasedOFFSIDES
21Blood glucose decreasedOFFSIDES
22Blood potassium increasedOFFSIDES
23Blood sodium increasedOFFSIDES
24Blood thyroid stimulating hormoneOFFSIDES
25Blood urea increasedOFFSIDES
26Body TemperatureOFFSIDES
27CYTOMEGALOVIRUS ANTIGENOFFSIDES
28Catheter related infectionOFFSIDES
29CheilitisOFFSIDES
30CholedocholithotomyOFFSIDES
31Concomitant disease progressionOFFSIDES
32Coronary angioplastyOFFSIDES
33CyanosisOFFSIDES
34Disseminated Intravascular CoagulationOFFSIDES
35Duodenal UlcerOFFSIDES
36Eosinophil percentage decreasedOFFSIDES
37Eosinophil percentage increasedOFFSIDES
38Eosinophilic PneumoniaOFFSIDES
39EpididymitisOFFSIDES
40Erosive gastritisOFFSIDES
41Erythema MultiformeOFFSIDES
42ErythemaOFFSIDES
43Febrile NeutropeniaOFFSIDES
44Feeling ColdOFFSIDES
45Gamma-Glutamyltransferase IncreasedOFFSIDES
46Gastric ulcerOFFSIDES
47GastroenteritisOFFSIDES
48Ileal Diseases18306037CTD
49ImmobileOFFSIDES
50Intestinal ObstructionOFFSIDES
51Intestinal PerforationOFFSIDES
52Jejunal Diseases18306037CTD
53Joint injuryOFFSIDES
54Leukopenia neonatalOFFSIDES
55Lip erosionOFFSIDES
56Lymph node palpableOFFSIDES
57Lymphocyte count decreasedOFFSIDES
58Lymphocyte percentage decreasedOFFSIDES
59Metastatic NeoplasmOFFSIDES
60Monocyte percentage increasedOFFSIDES
61Neutrophil count decreasedOFFSIDES
62Oropharyngeal painOFFSIDES
63Panic DisorderOFFSIDES
64PeritonitisOFFSIDES
65PleurisyOFFSIDES
66Pneumocystis jiroveci pneumoniaOFFSIDES
67PneumothoraxOFFSIDES
68Polymyalgia RheumaticaOFFSIDES
69Prepyloric stenosisOFFSIDES
70Pulmonary InfarctionOFFSIDES
71Renal tubular necrosisOFFSIDES
72Renin increasedOFFSIDES
73RhabdomyolysisOFFSIDES
74Septic arthritis staphylococcalOFFSIDES
75Shunt occlusionOFFSIDES
76Tension HeadacheOFFSIDES
77Tooth ExtractionOFFSIDES
78Treatment related secondary malignancyOFFSIDES
79Urinary bladder atrophyOFFSIDES
80Uterine CancerOFFSIDES
81Vertebral artery occlusionOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.